LY518674

Overview

LY518674 is a potent, selective PPARα agonist, with an EC 50 of 42 nM for human PPARα . LY518674 reduces triglycerides in and increased HDL-C and is used for the treatment of atherosclerosis.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Vitamin D Related/Nuclear Receptor | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > PPAR

Product Information

• Catalog No.: HY-50665
• CAS No.: 425671-29-0
• Molecular Formula: C23H27N3O4
• Molecular Weight: 409.48
• Purity: 98.50%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.08 mg/mL (5.08 mM); Clear solution
• Availability: In-stock

Source

Original product source